Lecture 13 - biologics Flashcards

1
Q

what is the definition of a biological ?

A

A biological medicine is a medicine that is derived from a biological (living) source, such as bacteria or viruses, blood, tissues, or living cells in culture. Examples are vaccines, insulin, monoclonal antibodies, blood coagulation factor and recombinant DNA proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is a monoclonal antibody definition?

A

Monoclonal antibodies are immunoglobulins (Ig) with a defined specificity derived from a monoclonal cell line. Their biological activities are characterised by a specific binding characteristic to a ligand (commonly known as antigen), and may be dependent on immune effector function such as antibody dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the 5 different types of antibodies based on heavy chain and light chain ?

A

IgA (α),

IgD (δ),

IgE (ε),

IgG (γ),

IgM (μ)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are IgG post-translational modification and glycosylation

A

Post-translational modifications (PTMs) are important quality characteristics that can impact drug stability, safety and efficacy.
- Serum half life, immunogenicity, PK characteristics of the mAb
PTMs occur during mAb production, purification and following administration.
Most common glycosylation and sites of glycosylation (mannose, Fucose, NAG, galactose)
Glycans play an important role in the immunity and recognition, therefore glycosylation must be controlled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how do mAbs exert their biological effects?

A

blocking

signallign

targeting

complement dependant cytotoxicity cdc

adcc - antibody dependant cell mediated cytotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are clinical indications for anti-CD20 chimeric monoclonal antibody ?

A

non-Hodgkin’s lymphoma
chronic lymphocytic leukemia
rheumatoid arthritis
idiopathic thrombocytopenic purpura
pemphigus vulgaris
myasthenia gravisbb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are physical drivers of mAb instability?

A

Can occur during any stage of product lifecycle.

During processing
Shear stress, Agitation, high pressure

During storage
Freeze-thaw, heat, light, extractables and leachables

During shipping, handling or in-use
Agitation, freeze-thaw, heat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

discusses the physical instability of monoclonal antibodies

A

Sequence-dependent
For example, low or high isoelectric points (PI) in the CDR or Aggregation-prone regions. isoelectric point is the pH at which a molecule carries no net electrical charge

product-dependant factors; Antibody concentration
Formulation excipients
Packaging (Extractables & Leachables)
Microbiological

Denaturation
Loss of higher order structure through unfolding

Protein Aggregation
- Where self-associate and polymerize into aggregates or organized fibrils.
Native vs non-native aggregates
Covalent vs non-covalent aggregates
Soluble aggregates (nanometers) to insoluble aggregates ((sub)-microns)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why does mAb aggregation matter?

A

Reduced efficacy
Increases immunogenicity (e.g. neutralizing antibodies)
Increased risk of anaphylaxis and allergic reactions
Increased risk of injection site reactions e.g. phlebitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are types of therapeutic mAbs?

A

murine - muromomab

chimeric - abciximab

humanised - daclizumab

human - adalimumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are types of antibody therapy ?

A

monoclonal antibodies

next generation: antibody drug conjugates, improved delivery strategies, glyco-engineered antibodies, antibody fragments and bispecifics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly